Dr. Daud Panah, MD

NPI: 1831239649
Total Payments
$2,505
2024 Payments
$206.83
Companies
17
Transactions
134
Medicare Patients
364
Medicare Billing
$264,929

Payment Breakdown by Category

Food & Beverage$2,353 (93.9%)
Other$107.81 (4.3%)
Education$44.03 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,353 121 93.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $107.81 1 4.3%
Education $44.03 12 1.8%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $573.42 59 $0 (2022)
Otsuka America Pharmaceutical, Inc. $435.99 14 $0 (2023)
ABBVIE INC. $384.88 14 $0 (2024)
ACADIA Pharmaceuticals Inc $221.08 2 $0 (2017)
Indivior Inc. $219.21 9 $0 (2021)
Teva Pharmaceuticals USA, Inc. $165.14 4 $0 (2023)
Janssen Pharmaceuticals, Inc $133.19 8 $0 (2024)
Alkermes, Inc. $72.79 5 $0 (2022)
Lundbeck LLC $71.88 4 $0 (2018)
Vanda Pharmaceuticals Inc. $58.29 4 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $206.83 6 ABBVIE INC. ($113.46)
2023 $179.87 6 ABBVIE INC. ($151.11)
2022 $196.91 14 ABBVIE INC. ($74.87)
2021 $290.93 19 Sunovion Pharmaceuticals Inc. ($91.59)
2020 $246.08 10 Otsuka America Pharmaceutical, Inc. ($109.41)
2019 $321.66 22 Teva Pharmaceuticals USA, Inc. ($137.50)
2018 $294.69 31 Sunovion Pharmaceuticals Inc. ($123.20)
2017 $767.92 26 ACADIA Pharmaceuticals Inc ($221.08)

All Payment Transactions

134 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/18/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $14.90 General
Category: Opioid Use Disorder
10/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $113.46 General
Category: NEUROSCIENCE
08/07/2024 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $17.75 General
Category: Neuroscience
06/10/2024 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $18.85 General
Category: Neuroscience
05/28/2024 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $23.45 General
Category: Neuroscience
03/11/2024 Janssen Pharmaceuticals, Inc INVEGA (Drug) Food and Beverage In-kind items and services $18.42 General
Category: Neuroscience
09/13/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.84 General
Category: NEUROSCIENCE
05/17/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $113.42 General
Category: NEUROSCIENCE
03/06/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $12.89 General
Category: Central Nervous System
02/28/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.35 General
Category: NEUROSCIENCE
02/09/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.50 General
Category: NEUROSCIENCE
02/08/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $15.87 General
Category: PSYCHIATRY
08/09/2022 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $16.66 General
Category: CNS
07/13/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.13 General
Category: NEUROSCIENCE
07/01/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $13.49 General
Category: CNS
06/13/2022 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $20.51 General
Category: CNS
05/23/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.64 General
Category: NEUROSCIENCE
05/23/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $11.95 General
Category: NEUROSCIENCE
05/05/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $14.52 General
Category: CNS
04/11/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.10 General
Category: NEUROSCIENCE
04/11/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $13.05 General
Category: NEUROSCIENCE
03/10/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $13.57 General
Category: CNS
03/07/2022 Vanda Pharmaceuticals Inc. HETLIOZ (Drug), FANAPT Food and Beverage In-kind items and services $14.99 General
Category: NON-24-HOUR SLEEP-WAKE DISORDER
03/01/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.00 General
Category: NEUROSCIENCE
02/04/2022 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $13.65 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 101 869 $134,600 $68,327
2022 2 71 714 $104,200 $56,309
2021 3 87 842 $127,400 $64,289
2020 3 105 1,085 $163,300 $76,004
Total Patients
364
Total Services
3,510
Medicare Billing
$264,929
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 34 360 $72,000 $37,044 51.5%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 38 400 $40,000 $22,185 55.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 93 $18,600 $6,920 37.2%
90791 Psychiatric diagnostic evaluation Office 2023 16 16 $4,000 $2,177 54.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 33 328 $65,600 $34,283 52.3%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 38 386 $38,600 $22,026 57.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 31 300 $60,000 $31,525 52.5%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 43 410 $41,000 $23,120 56.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 13 132 $26,400 $9,644 36.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 40 364 $72,800 $32,896 45.2%
90833 Psychotherapy, 30 minutes Office 2020 49 537 $53,700 $31,755 59.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 16 184 $36,800 $11,352 30.8%

About Dr. Daud Panah, MD

Dr. Daud Panah, MD is a Psychiatry healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831239649.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daud Panah, MD has received a total of $2,505 in payments from pharmaceutical and medical device companies, with $206.83 received in 2024. These payments were reported across 134 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,353).

As a Medicare-enrolled provider, Panah has provided services to 364 Medicare beneficiaries, totaling 3,510 services with total Medicare billing of $264,929. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Marlton, NJ
  • Active Since 02/08/2007
  • Last Updated 09/11/2024
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1831239649

Products in Payments

  • LATUDA (Drug) $573.42
  • VRAYLAR (Drug) $441.78
  • REXULTI (Drug) $274.34
  • ABILIFY MAINTENA (Drug) $233.53
  • NUPLAZID (Drug) $221.08
  • AUSTEDO (Drug) $150.39
  • SUBOXONE SUBLINGUAL FILM (Drug) $147.72
  • INVEGA (Drug) $78.47
  • SUBLOCADE (Drug) $71.49
  • ARISTADA (Drug) $54.91
  • TRINTELLIX (Drug) $40.97
  • INVEGA SUSTENNA (Drug) $40.73
  • HETLIOZ (Drug) $29.64
  • Aristada 441 mg (Drug) $17.88
  • Trintellix (Drug) $16.30
  • CAPLYTA (Drug) $16.05
  • BRIXADI (Drug) $14.90
  • Hetlioz (Drug) $14.89
  • SD809-TD (Drug) $14.75
  • SPRAVATO (Drug) $13.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Marlton